[1]
Emaran Sheikh Ismail, T.S., Bhangale, C., Ramanand, J. and Mahajan, H. 2021. Clinical outcome and toxicity in post-COVID suspected cases of mucormycosis treated with amphotericin B at dedicated COVID hospital: a prospective observational study. International Journal of Basic & Clinical Pharmacology. 10, 11 (Oct. 2021), 1271–1275. DOI:https://doi.org/10.18203/2319-2003.ijbcp20214116.